Evidence map›Paper›PMID 39196188›Full record

ArticleNature cardiovascular research2024

Cysteine-rich with EGF-like domains 2 (CRELD2) is an endoplasmic reticulum stress-inducible angiogenic growth factor promoting ischemic heart repair.

Xuekun Wu, Linqun Zheng, Marc R Reboll, Lillian F Hyde, Elvira Mass, Hans W Niessen, Maike Kosanke, Andreas Pich, Evangelos Giannitsis, Jochen Tillmanns and 6 more

Abstract read
In one paragraph

Article in Nature cardiovascular research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Xuekun Wu *Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Linqun Zheng *Division of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.ORCID 0009-0002-7663-0503
Marc R RebollDivision of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Lillian F HydeDivision of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Elvira MassDevelopmental Biology of the Immune System, Life & Medical Sciences Institute, University of Bonn, Bonn, Germany.ORCID 0000-0003-2318-2356
Hans W NiessenDepartment of Pathology and Department of Cardiac Surgery, Institute for Cardiovascular Research, Amsterdam University Medical Center, Amsterdam, The Netherlands.
Maike KosankeResearch Core Unit Genomics, Hannover Medical School, Hannover, Germany.
Andreas PichCore Unit Proteomics and Institute of Toxicology, Hannover Medical School, Hannover, Germany.
Evangelos GiannitsisDepartment of Medicine III, Heidelberg University, Heidelberg, Germany.
Jochen TillmannsDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.
Johann BauersachsDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-9341-117X
Joerg HeinekeDepartment of Cardiology and Angiology, Hannover Medical School, Hannover, Germany.ORCID 0000-0002-1541-3030
Yong WangDivision of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Mortimer Korf-KlingebielDivision of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Felix PoltenDivision of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany.
Kai C WollertDivision of Molecular and Translational Cardiology, Hans Borst Center for Heart and Stem Cell Research, Hannover Medical School, Hannover, Germany. wollert.kai@mh-hannover.de.ORCID 0000-0002-4890-4450

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) WO 552/12-1Niedersächsisches Ministerium für Wissenschaft und Kultur (Ministry for Science and Culture of Lower Saxony) VW-ZN3440
6 · The paper itself

Abstract

Tissue repair after myocardial infarction (MI) is guided by autocrine and paracrine-acting proteins. Deciphering these signals and their upstream triggers is essential when considering infarct healing as a therapeutic target. Here we perform a bioinformatic secretome analysis in mouse cardiac endothelial cells and identify cysteine-rich with EGF-like domains 2 (CRELD2), an endoplasmic reticulum stress-inducible protein with poorly characterized function. CRELD2 was abundantly expressed and secreted in the heart after MI in mice and patients. Creld2-deficient mice and wild-type mice treated with a CRELD2-neutralizing antibody showed impaired de novo microvessel formation in the infarct border zone and developed severe postinfarction heart failure. CRELD2 protein therapy, conversely, improved heart function after MI. Exposing human coronary artery endothelial cells to recombinant CRELD2 induced angiogenesis, associated with a distinct phosphoproteome signature. These findings identify CRELD2 as an angiogenic growth factor and unravel a link between endoplasmic reticulum stress and ischemic tissue repair.

Indexed as

Endoplasmic Reticulum StressEndothelial CellsMyocardial InfarctionNeovascularization, PhysiologicAngiogenesis Inducing AgentsAnimalsCell Adhesion MoleculesCells, CulturedDisease Models, AnimalExtracellular Matrix ProteinsHumansMaleMiceMice, Inbred C57BLMice, KnockoutSignal TransductionAngiogenesis Inducing AgentsCell Adhesion MoleculesCRELD2 protein, mouseExtracellular Matrix Proteins

Identifiers

PMID39196188
PMCPMC11358006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.